Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GNTA Genenta Science S.p.A.

Closed 06-05 16:00:00 EDT

2.04

+0.08

+4.08%

盘后1.84

-0.20-9.63%

19:56 EDT

High2.20	Low1.96	Vol748.29K
Open1.97	D1 Closing1.96	Amplitude12.24%
Mkt Cap48.13M	Tradable Cap22.90M	Total Shares23.59M
T/O1.53M	T/O Rate6.67%	Tradable Shares11.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GNTA","market":"US","secType":"STK","nameCN":"Genenta Science S.p.A.","latestPrice":2.04,"timestamp":1780689600000,"preClose":1.96,"halted":0,"volume":748287,"hourTrading":{"tag":"盘后","latestPrice":1.8435,"preClose":2.04,"latestTime":"19:56 EDT","volume":44830,"amount":86920.2142,"timestamp":1780703800947,"change":-0.1965,"changeRate":-0.096324,"amplitude":0.096324},"delay":0,"changeRate":0.04081632653061228,"floatShares":11223373,"shares":23591000,"eps":-0.388976,"marketStatus":"Closed","change":0.08,"latestTime":"06-05 16:00:00 EDT","open":1.97,"high":2.2,"low":1.96,"amount":1531259.2724823,"amplitude":0.122449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.388976,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1639544400000,"exchange":"NASDAQ","adjPreClose":1.96,"preHourTrading":{"tag":"盘前","latestPrice":1.9001,"preClose":1.96,"latestTime":"09:28 EDT","volume":30499,"amount":59833.112044299996,"timestamp":1780666119024,"change":-0.0599,"changeRate":-0.030561,"amplitude":0.081633},"postHourTrading":{"tag":"盘后","latestPrice":1.8435,"preClose":2.04,"latestTime":"19:56 EDT","volume":44830,"amount":86920.2142,"timestamp":1780703800947,"change":-0.1965,"changeRate":-0.096324,"amplitude":0.096324},"volumeRatio":0.050948},"requestUrl":"/m/hq/s/GNTA/wiki","defaultTab":"wiki","newsList":[{"id":"2640752955","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2640752955","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640752955?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:07","pubTimestamp":1780312058,"startTime":"0","endTime":"0","summary":"Genenta Science  shares were nearly 150% higher in Monday premarket activity, adding to a 15% rise in the previous session.Volato Group  stock was up 116%, extending gains from the earlier session.Hitek Global  shares were 103% higher following a 10.6% decline in the previous session.Hub Cyber Security  stock was up 94%, continuing from a 137% rally in the prior session.Namib Minerals  shares were 51% higher, extending Friday's 4.8% gain.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4134","BK4017","SOAR","BK4008","HKIT","HUBC","GNTA","NAMM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639267224","title":"Genenta Science completes acquisition of remaining 80.5% stake in A.T.C. for EUR 9.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639267224","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639267224?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:07","pubTimestamp":1780085262,"startTime":"0","endTime":"0","summary":"Genenta Science completed the acquisition of the remaining 80.5% stake in A.T.C. on May 29, 2026.Transaction valued at EUR 9.6 million, settled via set-off tied to A.T.C. shareholders’ subscription for 24,625,838 Genenta ordinary shares at EUR 0.39.Shares issued to the sellers carry a 36-month lock-up, with a ban on additional purchases of Genenta securities during that period.Sellers received a put option in years 3–5 if the 3-month VWAP falls more than 30% below EUR 0.39, exercisable at the floor price.Genenta received a call option in years 1–3 if the 3-month VWAP rises more than 30% above EUR 0.39, exercisable at EUR 0.51.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL34kcXV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631535701","title":"Genenta Science shifts focus to building industrial aggregator in Italy and Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2631535701","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631535701?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:25","pubTimestamp":1777407929,"startTime":"0","endTime":"0","summary":"Genenta set a new strategic direction to build an industrial aggregator in Italy and Europe.Operations in United States will be wound down through closure of wholly owned subsidiary Genenta Science, Inc.Cost base is set to be streamlined, with management targeting reduced expenses and sharper focus on core markets.Chief Financial Officer Richard B. Slansky will shift to a consulting role effective June 1, 2026, while remaining principal financial and accounting officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Ap","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL6CSHkd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629336598","title":"Genenta to invest EUR 6 million for 19.9% stake in Sophia High Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2629336598","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629336598?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:06","pubTimestamp":1776942383,"startTime":"0","endTime":"0","summary":"Genenta signed definitive agreements to invest EUR 6 million in Sòphia High Tech in two tranches.Closing first tranche gives Genenta a 19.9% stake.Second tranche is set to lift ownership to 51%.Funds are earmarked to scale production capacity, accelerate technology development, and expand commercial reach.Sòphia High Tech reported fiscal 2024 revenue of about EUR 6.29 million and EBITDA of about EUR 0.96 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief on April 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8Bkh0F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627421672","title":"Genenta gets Nasdaq notice after shares trade below $1 minimum bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2627421672","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627421672?lang=en_us&edition=fundamental","pubTime":"2026-04-15 04:10","pubTimestamp":1776197424,"startTime":"0","endTime":"0","summary":"Genenta received a Nasdaq notice on April 10, 2026 for failing to meet minimum $1 bid-price requirement under Listing Rule 5550.Nasdaq granted 180-day compliance window through Oct. 7, 2026 to regain compliance.Failure to cure by deadline could open path to another 180-day extension if Genenta qualifies for Nasdaq Capital Market standards, excluding bid price.Company is weighing remediation options, including potential reverse stock split if needed.Notice does not trigger immediate change to listing status for Genenta ADS.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL9SKgzl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624259482","title":"Genenta net loss narrows 27% to €6.5 million in FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2624259482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624259482?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:02","pubTimestamp":1775037745,"startTime":"0","endTime":"0","summary":"Genenta posted a net loss of EUR 6.5 million in fiscal 2025.Cash and cash equivalents totaled EUR 5.5 million, with marketable securities of EUR 22.6 million at Dec. 31, 2025.Funds on hand expected to cover operating expenses and capital expenditure needs at least until December 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDLK0RCQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622487841","title":"Genenta signs binding offer to acquire stake in Sòphia High Tech; funding totals EUR 6 million in two tranches","url":"https://stock-news.laohu8.com/highlight/detail?id=2622487841","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622487841?lang=en_us&edition=fundamental","pubTime":"2026-03-27 17:02","pubTimestamp":1774602122,"startTime":"0","endTime":"0","summary":"A binding offer was signed with Sòphia High Tech to fund the company through two reserved capital increases aimed at reaching a controlling stake after defined performance milestones are met.Total funding is expected to be EUR 6.0 million in two tranches, with the second tranche tied to performance.The transaction is planned to close in two phases and remains subject to confirmatory due diligence and required approvals.Sòphia High Tech is based in Italy and manufactures precision mechanical components and assemblies for space and defense programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief on March 27, 2026, and is solely responsible for the info","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL8RbhkC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622002140","title":"Genenta files initial beneficial ownership statement; Director Giacomoantonio Paracchi reports 0 ADSs","url":"https://stock-news.laohu8.com/highlight/detail?id=2622002140","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622002140?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:39","pubTimestamp":1774471186,"startTime":"0","endTime":"0","summary":"Genenta said director Giacomoantonio Paracchi filed an initial statement of beneficial ownership.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLbl93Wp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621068252","title":"Genenta continues to evaluate options for original biotechnology platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068252","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621068252?lang=en_us&edition=fundamental","pubTime":"2026-03-24 17:30","pubTimestamp":1774344653,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) announced that, with respect to its biotechnology platform, Genenta has been and continues to be actively engaged with DC Ad...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-continues-to-evaluate-options-for-original-biotechnology-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-continues-to-evaluate-options-for-original-biotechnology-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621515140","title":"Genenta to Reorganize as Saentra Forge Strategic Industrial Consolidator","url":"https://stock-news.laohu8.com/highlight/detail?id=2621515140","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621515140?lang=en_us&edition=fundamental","pubTime":"2026-03-24 15:27","pubTimestamp":1774337232,"startTime":"0","endTime":"0","summary":"Genenta said it is transforming into Saentra Forge, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies.The company said it is working with DC Advisory to explore collaboration options for its biotechnology platform, including Temferon.Genenta said DC Advisory has not identified potential strategic partners and the company is not in active discussions regarding Temferon or its biotechnology platform.CEO Pierluigi Paracchi said he has not sold his shares and has increased his position by purchasing ADSs during open trading windows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL91hqMD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","NDAQ","SG9999014039.USD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4139","GNTA","BK4112","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620267340","title":"Genenta Science files Form 3 as director Sharei Armon reports initial beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2620267340","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620267340?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:36","pubTimestamp":1773866191,"startTime":"0","endTime":"0","summary":"Genenta reported that director Armon Sharei filed an initial statement of beneficial ownership dated March 18, 2026. The filing reported 0 ordinary shares and 0 ADSs held directly. It also listed stock options to buy 20,163 ADSs at USD 3.08 per share, expiring July 1, 2034. Additional stock options covered 20,000 ADSs at USD 4.36 per share and 10,000 ADSs at USD 1.48 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLbbMjz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262384","title":"Genenta Science S.p.A. Director Miguel Maria Mutti Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262384","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262384?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:12","pubTimestamp":1773864740,"startTime":"0","endTime":"0","summary":"Genenta reported an initial statement of beneficial ownership by director Miguel Maria Mutti. The filing listed 33,333 Genenta American Depositary Shares beneficially owned directly. It also reported 0 Genenta ordinary shares beneficially owned directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4N30tJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620226287","title":"Genenta Science S.p.A. Director and CMO Francesco Galimi Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620226287","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620226287?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:11","pubTimestamp":1773864713,"startTime":"0","endTime":"0","summary":"Genenta Science filed an initial statement of beneficial ownership for Francesco Galimi, a director and an officer. Galimi’s officer title was listed as CMO and Head of Development. The filing reported 0 ordinary shares and 0 ADSs held directly. It also reported stock options for 20,000 ADSs with an exercise price of USD 4.36. A second stock option covered 27,110 ADSs with an exercise price of USD 2.57.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information containe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL35pb6l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262830","title":"Genenta Science CEO Pierluigi Paracchi Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262830","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262830?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:10","pubTimestamp":1773864640,"startTime":"0","endTime":"0","summary":"Genenta Science reported an initial statement of beneficial ownership by Pierluigi Paracchi, who is Chief Executive Officer and a director. Paracchi reported direct ownership of 2,275,516 ordinary shares. He also reported direct ownership of 27,000 American Depositary Shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1RDWDQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620628592","title":"Genenta Science files Form 3 initial beneficial ownership statement for CFO Richard B. Slansky","url":"https://stock-news.laohu8.com/highlight/detail?id=2620628592","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620628592?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:10","pubTimestamp":1773864610,"startTime":"0","endTime":"0","summary":"Genenta said Chief Financial Officer Richard Slansky filed an initial statement of beneficial ownership dated 03/18/2026. Slansky reported direct ownership of 19,947 ordinary shares. He also reported direct ownership of 2,200 ADSs. Slansky reported stock options covering 127,520 ADSs at an exercise price of USD 4.76. He also reported stock options covering 120,000 ADSs at an exercise price of USD 1.48.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL18GKcs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619672001","title":"Genenta CEO Pierluigi Paracchi joins Italian Academy at Columbia University board","url":"https://stock-news.laohu8.com/highlight/detail?id=2619672001","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619672001?lang=en_us&edition=fundamental","pubTime":"2026-03-13 17:00","pubTimestamp":1773392433,"startTime":"0","endTime":"0","summary":"Genenta said CEO Pierluigi Paracchi was appointed to the Board of Guarantors of the Italian Academy for Advanced Studies in America at Columbia University. The appointment was conferred by Deputy Prime Minister and Foreign Minister Antonio Tajani and transmitted by Italy’s Ambassador to the United States, Marco Peronaci. Genenta said the Board of Guarantors has 12 members, with six appointed by the Italian Government and six by Columbia University.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDLb08nCm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014039.USD","SG9999014013.SGD","LU2210150020.SGD","BK4112","LU2095319765.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ","BK4585","GNTA","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619167719","title":"Press Release: Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University","url":"https://stock-news.laohu8.com/highlight/detail?id=2619167719","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619167719?lang=en_us&edition=fundamental","pubTime":"2026-03-13 17:00","pubTimestamp":1773392400,"startTime":"0","endTime":"0","summary":"MILAN, March 13, 2026  -- Genenta Science S.p.A.  transforming to Saentra Forge  , a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that Pierluigi Paracchi, CEO of the Company, has been appointed as a member of the Board of Guarantors of the Italian Academy for Advanced Studies in America, the prestigious center for advanced scholarship hosted at Columbia University in New York, dedicated to promoting Italian culture, research, and intellectual exchange between Italy and the United States.The appointment was conferred by Deputy Prime Minister and Foreign Minister Antonio Tajani and transmitted by the Ambassador of Italy to the United States, Marco Peronaci. The Board of Guarantors is composed of twelve members: six appointed by the Italian Government and six by Columbia University.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4139","BK4588","GNTA","BK4555","BK4099","BK4585","BK4604","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614283339","title":"Genenta Science Appoints Paolo Salvato to ATC Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2614283339","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614283339?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:00","pubTimestamp":1772182837,"startTime":"0","endTime":"0","summary":"Genenta Science S.p.A., which is transitioning into Saentra Forge, announced the appointment of Paolo Salvato to the Board of Directors of ATC, its defense-technology manufacturing subsidiary. Salvato previously served as CEO of Fiocchi Munizioni, and earlier led Thales Italia and held senior roles at Leonardo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL5p9N1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","LU2210149790.SGD","LU2210150020.SGD","SG9999014021.USD","GNTA","SG9999014039.USD","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","SG9999014013.SGD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606830734","title":"Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2606830734","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606830734?lang=en_us&edition=fundamental","pubTime":"2026-01-28 01:45","pubTimestamp":1769535900,"startTime":"0","endTime":"0","summary":"Genenta plans a major shift into defense businesses, backing weapons maker ATC, rebranding as Saentra Forge and reshaping its future as shares see sharp moves.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/27/Business-Team-On-Meeting-To-Planning-Inv.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/27/Business-Team-On-Meeting-To-Planning-Inv.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/50166553/micro-cap-genenta-stock-reacts-to-its-big-pivot-from-biotech-to-defense-investments","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/50166553/micro-cap-genenta-stock-reacts-to-its-big-pivot-from-biotech-to-defense-investments","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["GNTA","BK4588","BK4217","BK4585","BK4139","LABU","SMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606788449","title":"Genenta Science to change name to Saentra Forge, seeks controlling stake in ATC","url":"https://stock-news.laohu8.com/highlight/detail?id=2606788449","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606788449?lang=en_us&edition=fundamental","pubTime":"2026-01-27 18:25","pubTimestamp":1769509523,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) intends to target majority ownership in companies with established operating profitability, typically generating up to appro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-science-to-change-name-to-saentra-forge-seeks-controlling-stake-in-atc-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-science-to-change-name-to-saentra-forge-seeks-controlling-stake-in-atc-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNTA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genenta.com","stockEarnings":[{"period":"1week","weight":1.1899},{"period":"1month","weight":1.9254},{"period":"3month","weight":1.2788},{"period":"6month","weight":0.0481},{"period":"1year","weight":-0.5505},{"period":"ytd","weight":0.3154}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.046},{"period":"3month","weight":0.126},{"period":"6month","weight":0.1041},{"period":"1year","weight":0.2704},{"period":"ytd","weight":0.1102}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.166493},{"month":2,"riseRate":0.8,"avgChangeRate":0.008875},{"month":3,"riseRate":0.4,"avgChangeRate":-0.111332},{"month":4,"riseRate":0.4,"avgChangeRate":-0.041927},{"month":5,"riseRate":1,"avgChangeRate":0.216387},{"month":6,"riseRate":0.2,"avgChangeRate":0.073435},{"month":7,"riseRate":0.5,"avgChangeRate":0.127248},{"month":8,"riseRate":0.25,"avgChangeRate":-0.038742},{"month":9,"riseRate":0.25,"avgChangeRate":-0.080469},{"month":10,"riseRate":0.5,"avgChangeRate":-0.019257},{"month":11,"riseRate":0.5,"avgChangeRate":-0.009911},{"month":12,"riseRate":0.25,"avgChangeRate":-0.103818}],"exchange":"NASDAQ","name":"Genenta Science S.p.A.","nameEN":"Genenta Science S.p.A.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Genenta Science S.p.A.(GNTA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Genenta Science S.p.A.,GNTA,Genenta Science S.p.A.股票,Genenta Science S.p.A.股票老虎,Genenta Science S.p.A.股票老虎国际,Genenta Science S.p.A.行情,Genenta Science S.p.A.股票行情,Genenta Science S.p.A.股价,Genenta Science S.p.A.股市,Genenta Science S.p.A.股票价格,Genenta Science S.p.A.股票交易,Genenta Science S.p.A.股票购买,Genenta Science S.p.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Genenta Science S.p.A.(GNTA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction